Showing results (21-30 of 299) with videos related to

Sort By:
Pageof 30
Anti-Cancer Drugs|March 1, 1997
Phase II trial of continuous oral trofosfamide in patients with advanced colorectal cancer refractory to 5-fluorouracilD Strumberg, A Harstrick, U Klaassen, et al.
Oncology Research|January 1, 1997
Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cellsU Vanhoefer, W Voigt, R A Hilger, et al.
Anti-Cancer Drugs|July 11, 1998
Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancerJ T Hartmann, A Harstrick, T Daikeler, et al.
Cancer Chemotherapy and Pharmacology|July 8, 1998
Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumorsR A Hilger, A Harstrick, W Eberhardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Weekly high-dose 5-fluorouracil and folinic acid as salvage treatment in advanced gastric cancerU Vanhoefer, H Wilke, H J Weh, et al.
Oncology (Williston Park, N.Y.)|April 1, 1997
Infusional 5-FU, folinic acid, paclitaxel, and cisplatin for metastatic breast cancerU Klaassen, H Wilke, C Müller, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancerH Wilke, P Preusser, M Stahl, et al.
Seminars in Oncology|December 1, 1995
Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysisU Klaassen, H Wilke, C P Pari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 1997
Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate (PALA) is inactive in advanced pancreatic carcinomaA Harstrick, C H Köhne, W Hiddemann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I studyM Tewes, N Schleucher, W Achterrath, et al.
Pageof 30